Fig. 3From: Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trialIslet β-cell function and insulin resistance after treatment with UC-MSCs or placebo. *p < 0.05, **p < 0.01, ***p < 0.001 between both groups; #p < 0.05; ## p < 0.01; ###p < 0.001 versus baseline values. GIR, glucose infusion rateBack to article page